BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 22470132)

  • 1. SRT1720, a SIRT1 activator, promotes tumor cell migration, and lung metastasis of breast cancer in mice.
    Suzuki K; Hayashi R; Ichikawa T; Imanishi S; Yamada T; Inomata M; Miwa T; Matsui S; Usui I; Urakaze M; Matsuya Y; Ogawa H; Sakurai H; Saiki I; Tobe K
    Oncol Rep; 2012 Jun; 27(6):1726-32. PubMed ID: 22470132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sirtuin 1 activator SRT1720 suppresses inflammation in an ovalbumin-induced mouse model of asthma.
    Ichikawa T; Hayashi R; Suzuki K; Imanishi S; Kambara K; Okazawa S; Inomata M; Yamada T; Yamazaki Y; Koshimizu Y; Miwa T; Matsui S; Usui I; Urakaze M; Matsuya Y; Sasahara M; Tobe K
    Respirology; 2013 Feb; 18(2):332-9. PubMed ID: 23062010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SRT1720 induces lysosomal-dependent cell death of breast cancer cells.
    Lahusen TJ; Deng CX
    Mol Cancer Ther; 2015 Jan; 14(1):183-92. PubMed ID: 25411356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SIRT1 activation by SRT1720 attenuates bone cancer pain via preventing Drp1-mediated mitochondrial fission.
    Li MY; Ding JQ; Tang Q; Hao MM; Wang BH; Wu J; Yu LZ; Jiao M; Luo BH; Xie M; Zhu HL
    Biochim Biophys Acta Mol Basis Dis; 2019 Mar; 1865(3):587-598. PubMed ID: 30579931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Sirt1 activator, SRT1720, attenuates renal fibrosis by inhibiting CTGF and oxidative stress.
    Ren Y; Du C; Shi Y; Wei J; Wu H; Cui H
    Int J Mol Med; 2017 May; 39(5):1317-1324. PubMed ID: 28339034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The beneficial role of SIRT1 activator on chemo- and radiosensitization of breast cancer cells in response to IL-6.
    Masoumi H; Soltani A; Ghatrehsamani M
    Mol Biol Rep; 2020 Jan; 47(1):129-139. PubMed ID: 31781916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment with SRT1720, a SIRT1 activator, ameliorates fatty liver with reduced expression of lipogenic enzymes in MSG mice.
    Yamazaki Y; Usui I; Kanatani Y; Matsuya Y; Tsuneyama K; Fujisaka S; Bukhari A; Suzuki H; Senda S; Imanishi S; Hirata K; Ishiki M; Hayashi R; Urakaze M; Nemoto H; Kobayashi M; Tobe K
    Am J Physiol Endocrinol Metab; 2009 Nov; 297(5):E1179-86. PubMed ID: 19724016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Naringenin prevents TGF-β1 secretion from breast cancer and suppresses pulmonary metastasis by inhibiting PKC activation.
    Zhang F; Dong W; Zeng W; Zhang L; Zhang C; Qiu Y; Wang L; Yin X; Zhang C; Liang W
    Breast Cancer Res; 2016 Apr; 18(1):38. PubMed ID: 27036297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cucurbitacin E inhibits breast tumor metastasis by suppressing cell migration and invasion.
    Zhang T; Li J; Dong Y; Zhai D; Lai L; Dai F; Deng H; Chen Y; Liu M; Yi Z
    Breast Cancer Res Treat; 2012 Sep; 135(2):445-58. PubMed ID: 22842972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Licochalcone E present in licorice suppresses lung metastasis in the 4T1 mammary orthotopic cancer model.
    Kwon SJ; Park SY; Kwon GT; Lee KW; Kang YH; Choi MS; Yun JW; Jeon JH; Jun JG; Park JH
    Cancer Prev Res (Phila); 2013 Jun; 6(6):603-13. PubMed ID: 23625311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SIRT1 upregulation protects against liver injury induced by a HFD through inhibiting CD36 and the NF‑κB pathway in mouse kupffer cells.
    Niu B; He K; Li P; Gong J; Zhu X; Ye S; Ou Z; Ren G
    Mol Med Rep; 2018 Aug; 18(2):1609-1615. PubMed ID: 29845302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific Sirt1 Activator-mediated Improvement in Glucose Homeostasis Requires Sirt1-Independent Activation of AMPK.
    Park SJ; Ahmad F; Um JH; Brown AL; Xu X; Kang H; Ke H; Feng X; Ryall J; Philp A; Schenk S; Kim MK; Sartorelli V; Chung JH
    EBioMedicine; 2017 Apr; 18():128-138. PubMed ID: 28396013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SIRTUIN 1 ACTIVATOR SRT1720 PROTECTS AGAINST ORGAN INJURY INDUCED BY INTESTINAL ISCHEMIA-REPERFUSION.
    Hansen LW; Khader A; Yang WL; Prince JM; Nicastro JM; Coppa GF; Wang P
    Shock; 2016 Apr; 45(4):359-66. PubMed ID: 26263437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SIRT1 and AMPK mediate hypoxia-induced resistance of non-small cell lung cancers to cisplatin and doxorubicin.
    Shin DH; Choi YJ; Park JW
    Cancer Res; 2014 Jan; 74(1):298-308. PubMed ID: 24240701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Effects of SRT1720 Treatment on Endothelial Cells Derived from the Lung and Bone Marrow of Young and Aged, Male and Female Mice.
    Dadwal UC; Bhatti FUR; Awosanya OD; Staut CA; Nagaraj RU; Perugini AJ; Tewari NP; Valuch CR; Sun S; Mendenhall SK; Zhou D; Mostardo SL; Blosser RJ; Li J; Kacena MA
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SRT1720 induces SIRT1-independent cell death in adult T-cell leukemia/lymphoma.
    Kozako T; Kato N; Ohsugi T; Uchida YI; Yoshimitsu M; Ishitsuka K; Higaki Y; Sato H; Aikawa A; Honda SI
    FEBS J; 2022 Jun; 289(12):3477-3488. PubMed ID: 35029032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The SIRT1 activator SRT1720 reverses vascular endothelial dysfunction, excessive superoxide production, and inflammation with aging in mice.
    Gano LB; Donato AJ; Pasha HM; Hearon CM; Sindler AL; Seals DR
    Am J Physiol Heart Circ Physiol; 2014 Dec; 307(12):H1754-63. PubMed ID: 25326534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reverse chemomodulatory effects of the SIRT1 activators resveratrol and SRT1720 in Ewing's sarcoma cells: resveratrol suppresses and SRT1720 enhances etoposide- and vincristine-induced anticancer activity.
    Sonnemann J; Kahl M; Siranjeevi PM; Blumrich A; Blümel L; Becker S; Wittig S; Winkler R; Krämer OH; Beck JF
    J Cancer Res Clin Oncol; 2016 Jan; 142(1):17-26. PubMed ID: 26055805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Sirt1 activator SRT1720 attenuates angiotensin II-induced atherosclerosis in apoE⁻/⁻ mice through inhibiting vascular inflammatory response.
    Chen YX; Zhang M; Cai Y; Zhao Q; Dai W
    Biochem Biophys Res Commun; 2015 Oct; 465(4):732-8. PubMed ID: 26296466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SIRT1-independent mechanisms of the putative sirtuin enzyme activators SRT1720 and SRT2183.
    Huber JL; McBurney MW; Distefano PS; McDonagh T
    Future Med Chem; 2010 Dec; 2(12):1751-9. PubMed ID: 21428798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.